These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7547497)

  • 1. Flow cytometric analysis of c-myc oncoprotein in non-small-cell lung carcinoma: comparison with immunohistochemical results.
    De Santis L; Mangili F; Sassi I; Di Rocco M; Rossi C; Cantaboni A
    Anal Cell Pathol; 1995 Apr; 8(3):247-57. PubMed ID: 7547497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
    Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
    Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
    Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
    J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric and immunohistochemical analysis of p62c-myc oncoprotein in the bronchial epithelium of lung cancer patients.
    Sundaresan V; Reeve JG; Wilson B; Bleehen NM; Watson JV
    Anticancer Res; 1991; 11(6):2111-6. PubMed ID: 1776848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
    Volm M; Koomägi R
    Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative detection of lymph node micrometastasis with flow cytometry in non-small cell lung cancer.
    Ito M; Minamiya Y; Kawai H; Saito S; Saito H; Imai K; Ogawa J
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):753-8. PubMed ID: 16153924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prognostic value of cytokeratin 19 expression in non-small cell lung cancer].
    Kosacka M; Jankowska R
    Pneumonol Alergol Pol; 2007; 75(4):317-23. PubMed ID: 18080980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-erbB-2 oncoprotein expression in operable non-small cell lung cancer.
    Giatromanolaki A; Gorgoulis V; Chetty R; Koukourakis MI; Whitehouse R; Kittas C; Veslemes M; Gatter KC; Iordanoglou I
    Anticancer Res; 1996; 16(2):987-93. PubMed ID: 8687165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
    Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
    Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types.
    Gosney JR; Field JK; Gosney MA; Lye MD; Spandidos DA; Butt SA
    Anticancer Res; 1990; 10(3):623-8. PubMed ID: 2164348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
    Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
    Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 labeling indices in non-small cell lung cancer: comparison between image cytometry and flow cytometry.
    Ishikuro A; Dosaka-Akita H; Kato M; Fujino M; Isobe H; Miyamoto H; Inoue K; Kawakami Y
    Cytometry; 1997 Aug; 30(4):186-91. PubMed ID: 9298837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA content analysis and detection of c-myc and p53 products using flow cytometry in resected lung cancer cases].
    Chiba W; Sawai S; Ikeda S; Morimoto K; Wazawa H; Hanawa T; Yamashita N; Matsui T; Hatakenaka R; Matsubara Y
    Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():108-16. PubMed ID: 8203922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas.
    Mørkve O; Halvorsen OJ; Skjaerven R; Stangeland L; Gulsvik A; Laerum OD
    Anticancer Res; 1993; 13(3):571-8. PubMed ID: 8391242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric measurement of p53 protein expression and DNA content in paraffin-embedded tissue from bronchial carcinomas.
    Mørkve O; Laerum OD
    Cytometry; 1991; 12(5):438-44. PubMed ID: 1935458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas.
    Volm M
    Anticancer Res; 1993; 13(2):375-8. PubMed ID: 8100127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
    Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
    Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The implications of proliferation and apoptosis for lung cancer metastasis.
    Volm M; Koomagi R
    Oncol Rep; 1999; 6(2):373-6. PubMed ID: 10023008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.